A Review of the Key Clinical Trials of 2014.

Cardiol Ther · 2015 · PMC4472645 · PMID 25814425

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Nevertheless, assuming LCZ696 receives a license, it is likely to be quickly included in clinical HF guidelines given its highly significant reduction in CV mortality and all-cause mortality.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.